Onabotulinum toxin A in the treatment of chronic migraine: patient selection and special considerations

Onabotulinum toxin A in the treatment of chronic migraine: patient selection and special considerations

Piero Barbanti,1 Patrizia Ferroni2 1Headache and Pain Unit, Department of Neurological, Motor and Sensorial Sciences, 2Department of Human Sciences and Quality of Life Promotion, San Raffaele Roma Open University, IRCCS San Raffaele Pisana, Rome, Italy Abstract: Discovered by serendipity, onabotulin...

Full description

Bibliographic Details
Main Authors:	Barbanti P, Ferroni P
Format:	Article
Language:	English
Published:	Dove Medical Press 2017-09-01
Series:	Journal of Pain Research
Subjects:	chronic migraine onabotulinum toxin A prophylaxis treatment responder patient selection
Online Access:	https://www.dovepress.com/onabotulinum-toxin-a-in-the-treatment-of-chronic-migraine-patient-sele-peer-reviewed-article-JPR

Similar Items

A New Treatment Option for Vestibular Migraine: Onabotulinum Toxin Type A
by: Reyhan Sürmeli, et al.
Published: (2020-05-01)

Stopping Onabotulinum Treatment after the First Two Cycles Might Not Be Justified: Results of a Real-life Monocentric Prospective Study in Chronic Migraine
by: Paola Sarchielli, et al.
Published: (2017-12-01)

Efficacy of Onabotulinum Toxin A on Obsessive–Compulsive Traits in a Population of Chronic Migraine Patients
by: Giovanna Viticchi, et al.
Published: (2022-11-01)

ONABOTULINUM TOXIN-A FOR OVERACTIVE BLADDER
by: Mahmood Shakir Abdulkarim
Published: (2016-12-01)

The Role of Onabotulinum Toxin Type A in the Management of Chronic Non-migraine Headaches
by: Cassie Jia, et al.
Published: (2019-09-01)

Chronic Migraine: A Narrative Review on the Use of Botulinum Toxin with Clinical Indications and Future Directions
by: Loredana Raciti, et al.
Published: (2022-08-01)

New injection points of onabotulinum toxin a for spastic paralysis of the fingers: Eight cases of report
by: Shoko Merrit Yamada, et al.
Published: (2020-01-01)

Outcomes of Intradetrusor Onabotulinum Toxin A Therapy in Overactive Bladder Refractory to Sacral Neuromodulation
by: Hamilton Trinh, et al.
Published: (2019-09-01)

Sustained Efficacy, Safety and High Adherence Rate of Onabotulinum Toxin Type A in Chronic Migraine Patients: A Multicentric Prospective Real-Life Study
by: Ilenia Corbelli, et al.
Published: (2022-12-01)

Adult Abdominal Migraine Improved by OnabotulinumtoxinA Injections
by: Neal Hermanowicz
Published: (2021-09-01)

Efficacy and Safety of Letibotulinum Toxin A for the Treatment of Dynamic Equinus Foot Deformity in Children with Cerebral Palsy: A Randomized Controlled Trial
by: Hyun Jung Chang, et al.
Published: (2017-08-01)

Effect of botulinum toxin on improving quality of life in patients with chronic migraine
by: Magdalena Marzęda, et al.
Published: (2022-09-01)

Botulinum Toxin for the Treatment of Hemifacial Spasm: An Update on Clinical Studies
by: Nicola Tambasco, et al.
Published: (2021-12-01)

Onabotulinum Toxin A Intradetrusor Injections in Children with Neurogenic Lower Urinary Tract Dysfunction: Long-Term Histological Effects on the Bladder Wall
by: Chiara Pellegrino, et al.
Published: (2023-04-01)

Botulinum toxin type A in treatment of chronic migraine, spasticity and bruxism
by: Klaudia Kuliga, et al.
Published: (2023-05-01)

Real-World Evaluation of the Tolerability to Onabotulinum Toxin A: The RETO Study
by: David García-Azorín, et al.
Published: (2022-12-01)

A Proposal for Botulinum Toxin Type A Injection Into the Temporal Region in Chronic Migraine Headache
by: Young-gun Kim, et al.
Published: (2020-03-01)

Differences in Botulinum Toxin Injection Into Temporal Muscles in Sleep Bruxism and Chronic Migraine
by: Jung Eun Lee, et al.
Published: (2022-06-01)

Acupuncture and botulinum toxin A injection in the treatment of chronic migraine: A randomized controlled study
by: Bahram Naderinabi, et al.
Published: (2017-06-01)

Incobotulinum Toxin-A Improves Post-Surgical and Post-Radiation Pain in Cancer Patients
by: Rezvan Rostami, et al.
Published: (2016-01-01)

Onabotulinumtoxin A for the management of chronic migraine in current clinical practice: results of a survey of sixty-three Italian headache centers
by: Cristina Tassorelli, et al.
Published: (2017-06-01)

Conversion Ratio between Botox®, Dysport®, and Xeomin® in Clinical Practice
by: Francesco Scaglione
Published: (2016-03-01)

Botulinum Toxin a Valuable Prophylactic Agent for Migraines and a Possible Future Option for the Prevention of Hormonal Variations-Triggered Migraines
by: Lorena Dima, et al.
Published: (2019-08-01)

Effectiveness and Safety of Intradetrusor OnabotulinumtoxinA Injection for Neurogenic Detrusor Overactivity and Overactive Bladder Patients in Taiwan—A Phase IV Prospective, Interventional, Multiple-Center Study (Restore Study)
by: Chung-Cheng Wang, et al.
Published: (2021-12-01)

Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins
by: Sara M. Schaefer, et al.
Published: (2015-07-01)

The Treatment of Facial Asymmetry with Botulinum Toxin: Current Concepts, Guidelines, and Future Trends
by: Izolda Heydenrych
Published: (2020-08-01)

Effect of Intratrigonal Botulinum Toxin in Patients with Bladder Pain Syndrome/Interstitial Cystitis: A Long-Term, Single-Center Study in Real-Life Conditions
by: Pedro Abreu-Mendes, et al.
Published: (2022-11-01)

Effects of Botulinum Toxin on Migraine Attack Features in Chronic Migraine: A Six-Month Open-Label Observation Study through Electronic Diary Smartphone Application
by: Antonio Santoro, et al.
Published: (2019-11-01)

‘Possessed’: Acute Confusional Migraine in an Adolescent, Prevented by Topiramate
by: Eugenia Rota, et al.
Published: (2012-12-01)

Benefits Beyond Headache Days With OnabotulinumtoxinA Treatment: A Pooled PREEMPT Analysis
by: Hans-Christoph Diener, et al.
Published: (2020-10-01)

Botulinum Toxin—A Current Place in the Treatment of Chronic Migraine and Other Primary Headaches
by: Katarzyna Kępczyńska, et al.
Published: (2022-09-01)

Clinical experience with transcutaneous supraorbital nerve stimulation in patients with refractory migraine or with migraine and intolerance to topiramate: a prospective exploratory clinical study
by: Michail Vikelis, et al.
Published: (2017-05-01)

The Treatment of Vestibular Migraine: A Narrative Review
by: Youjin Shen, et al.
Published: (2020-01-01)

Patient Experience of Flunarizine for Vestibular Migraine: Single Centre Observational Study
by: Sk Mamun Ur Rashid, et al.
Published: (2022-03-01)

The effectiveness of propranolol, flunarizine, amitriptyline and botulinum toxin in vestibular migraine complaints and prophylaxis: a non-randomized controlled study
by: Kemal Görür, et al.
Published: (2022-11-01)

Effectiveness of cyproheptadine in the prevention of childhood migraine
by: Zulkarnain Zulkarnain, et al.
Published: (2009-10-01)

Botulinum Toxin in the Treatment of Headache
by: Werner J. Becker
Published: (2020-12-01)

Evaluation of Efficacy and Safety of Propranolol for Pediatric Migraine Prophylaxis
by: M Ordooei, et al.
Published: (2013-04-01)

Urethral Sphincter Botulinum Toxin A Injection for Non-Spinal Cord Injured Patients with Voiding Dysfunction without Anatomical Obstructions: Which Patients Benefit Most?
by: Sheng-Fu Chen, et al.
Published: (2023-01-01)

Efficacy of mindfulness added to treatment as usual in patients with chronic migraine and medication overuse headache: a phase-III single-blind randomized-controlled trial (the MIND-CM study)
by: Licia Grazzi, et al.
Published: (2023-07-01)